Form Type: 4

SEC EDGAR Link
Accession Number:0001708138-21-000018
Date:2021-05-07
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
Original Submission Date:

Reporting Person:

MCCOURT MARION
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-07 M 1,000 a $342.93 18,038 direct
COMMON STOCK 2021-05-07 S 1,000 d $495.63 17,038 direct
COMMON STOCK 0 $0.00 108 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 342.93 2021-05-07 deemed execution date M 1,000 (d) 2028-02-12 common stock 1,000 $342.93 17,000 direct
Footnotes
IDfootnote
f1 represents volume-weighted average price of sales of 1,000 shares of company stock on may 7, 2021 at prices ranging from $495.47 to $495.70. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on may 7, 2021 at each separate price.
f2 the stock option award vests in four equal annual installments, commencing one year after the date of grant.

Elevate your investments